Targeted Inhibition of FTO Demethylase Protects Mice Against LPS-Induced Septic Shock by Suppressing NLRP3 Inflammasome

  • Jiahui Luo
  • , Faxi Wang
  • , Fei Sun
  • , Tiantian Yue
  • , Qing Zhou
  • , Chunliang Yang
  • , Shanjie Rong
  • , Ping Yang
  • , Fei Xiong
  • , Qilin Yu
  • , Shu Zhang
  • , Cong Yi Wang*
  • , Jinxiu Li*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Sepsis refers to the systemic inflammatory response syndrome caused by infection. It is a major clinical problem and cause of death for patients in intensive care units worldwide. The Fat mass and obesity-related protein (FTO) is the primary N6-methyladenosine demethylase. However, the role of FTO in the pathogenesis of inflammatory diseases remains unclear. We herein show that nanoparticle-mediated Fto-siRNA delivery or FTO inhibitor entacapone administration dramatically inhibited macrophage activation, reduced the tissue damage and improved survival in a mouse model of LPS-induced endotoxic shock. Importantly, ablation of FTO could inhibit NLRP3 inflammasome through FoxO1/NF-κB signaling in macrophages. In conclusion, FTO is involved in inflammatory response of LPS-induced septic shock and inhibition of FTO is promising for the treatment of septic shock.

Original languageEnglish
Article number663295
JournalFrontiers in Immunology
Volume12
DOIs
Publication statusPublished - 4 May 2021
Externally publishedYes

Keywords

  • entacapone
  • FTO
  • inflammasome
  • N-methyladenosine
  • sepsis

Fingerprint

Dive into the research topics of 'Targeted Inhibition of FTO Demethylase Protects Mice Against LPS-Induced Septic Shock by Suppressing NLRP3 Inflammasome'. Together they form a unique fingerprint.

Cite this